Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

German scientists disclose new HIF-mediated transcription inhibitors

July 21, 2010

CytRx advances its bafetinib program in oncology

July 21, 2010

Archer Biosciences begins dosing in third cohort of TPI-287 trial in metastatic melanoma

July 21, 2010

Hexyl/methyl aminolevulinate photodynamic therapy does not damage cervical tissue

July 21, 2010

Ziopharm begins phase III palifosfamide trial in metastatic soft tissue sarcoma

July 21, 2010

Geron begins phase II imetelstat trial in advanced non-small cell lung cancer

July 20, 2010

Jevtana launched in U.S. for metastatic hormone-refractory prostate cancer

July 20, 2010

Health Canada clears phase III ReoT3D trial in head and neck cancer

July 20, 2010

FDA approves Lorus Therapeutics' IND for anticancer agent LOR-253

July 20, 2010

Amgen's denosumab BLA receives FDA priority review status

July 19, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...